Literature DB >> 15319383

Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF.

E M Kolibianakis1, K Zikopoulos, J Schiettecatte, J Smitz, H Tournaye, M Camus, A C Van Steirteghem, P Devroey.   

Abstract

BACKGROUND: The significance of suppressed LH levels in GnRH antagonist cycles for IVF outcome is currently unknown. The purpose of this study was to evaluate prospectively the association between LH levels and ongoing pregnancy achievement after GnRH antagonist initiation in IVF cycles.
METHODS: Ovarian stimulation with a fixed dose of 200 IU recombinant FSH and daily GnRH antagonist (ganirelix) 0.25 mg from day 6 of stimulation was initiated in 116 women. Patients were not pretreated with an oral contraceptive. Induction of final oocyte maturation was performed with HCG 10,000 IU as soon as three follicles of > or =17 mm were present in ultrasound, and was followed by oocyte pick-up, conventional IVF or ICSI, and embryo transfer. The luteal phase was supplemented with vaginal progesterone.
RESULTS: A significant decrease of both ongoing pregnancy rate and implantation rate was present across groups of patients with increasing LH levels. The highest implantation rate and ongoing pregnancy rate was present in those patients with LH levels on day 8 of stimulation < or =0.5 IU/l.
CONCLUSIONS: Profound suppression of LH on day 8 of stimulation is associated with a significantly higher chance of achieving an ongoing pregnancy. More studies are necessary to evaluate this phenomenon further.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319383     DOI: 10.1093/humrep/deh471

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age?

Authors:  Carla Schmitz; Silvina Bocca; Hind Beydoun; Laurel Stadtmauer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2012-06-23       Impact factor: 3.412

2.  Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART.

Authors:  Barbara Sonntag; Ludwig Kiesel; Eberhard Nieschlag; Hermann M Behre
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

3.  IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.

Authors:  Hong Ye; Guo-ning Huang; Ping-hong Zeng; Li Pei
Journal:  J Assist Reprod Genet       Date:  2009-02-19       Impact factor: 3.412

4.  What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.

Authors:  Y Ganor-Paz; Y Friedler-Mashiach; Y Ghetler; A Hershko-Klement; A Berkovitz; O Gonen; A Shulman; A Wiser
Journal:  J Endocrinol Invest       Date:  2016-01-21       Impact factor: 4.256

5.  Clinical effects of a natural extract of urinary human menopausal gonadotrophin in normogonadotropic infertile patients.

Authors:  Rui Hua; Lan Ma; Hong Li
Journal:  Int J Reprod Med       Date:  2013-03-24

6.  A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.

Authors:  P Devroey; R Boostanfar; N P Koper; B M J L Mannaerts; P C Ijzerman-Boon; B C J M Fauser
Journal:  Hum Reprod       Date:  2009-08-14       Impact factor: 6.918

7.  Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.

Authors:  Haiyan Lin; Yu Li; Lin Li; Wenjun Wang; Dongzi Yang; Qingxue Zhang
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

8.  Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT.

Authors:  Raffaella Depalo; Paolo Trerotoli; Annarosa Chincoli; Margherita Patrizia Vacca; Giuseppina Lamanna; Ettore Cicinelli
Journal:  Int J Reprod Biomed       Date:  2018-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.